In an Alzheimer’s disease model, ALA has been demonstrated to inhibit the formation of •OH and reduce the expression of inducible nitric oxide synthase (iNOS) and nitric oxide (NO), thereby indirectly mitigating disease progression [10]. The gene discussed is NOS2; the disease is early-onset autosomal dominant Alzheimer disease.